Search

Nita M. Minnifield

Examiner (ID: 17178, Phone: (571)272-0860 , Office: P/1645 )

Most Active Art Unit
1645
Art Unit(s)
1817, 1621, 1645, 1802, 1813
Total Applications
1564
Issued Applications
1017
Pending Applications
126
Abandoned Applications
425

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16459532 [patent_doc_number] => 10842860 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-11-24 [patent_title] => AipA, OmpA, and Asp14 in vaccine compositions and diagnostic targets for Anaplasma phagocytophilum infection [patent_app_type] => utility [patent_app_number] => 16/105048 [patent_app_country] => US [patent_app_date] => 2018-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 71 [patent_no_of_words] => 30852 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16105048 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/105048
AipA, OmpA, and Asp14 in vaccine compositions and diagnostic targets for Anaplasma phagocytophilum infection Aug 19, 2018 Issued
Array ( [id] => 16771103 [patent_doc_number] => 10982198 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-04-20 [patent_title] => Compositions and methods relating to a mutant [patent_app_type] => utility [patent_app_number] => 16/104938 [patent_app_country] => US [patent_app_date] => 2018-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 63 [patent_no_of_words] => 67070 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16104938 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/104938
Compositions and methods relating to a mutant Aug 18, 2018 Issued
Array ( [id] => 16451074 [patent_doc_number] => 20200360500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-19 [patent_title] => PNEUMOCOCCAL CONJUGATE VACCINE FORMULATIONS [patent_app_type] => utility [patent_app_number] => 16/638846 [patent_app_country] => US [patent_app_date] => 2018-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17712 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -49 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16638846 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/638846
PNEUMOCOCCAL CONJUGATE VACCINE FORMULATIONS Aug 12, 2018 Abandoned
Array ( [id] => 16459530 [patent_doc_number] => 10842858 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-11-24 [patent_title] => Compositions and methods of enhancing immune responses to [patent_app_type] => utility [patent_app_number] => 16/028599 [patent_app_country] => US [patent_app_date] => 2018-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 6672 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16028599 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/028599
Compositions and methods of enhancing immune responses to Jul 5, 2018 Issued
Array ( [id] => 15990473 [patent_doc_number] => 20200171107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-04 [patent_title] => HIGH POTENCY STABLE FORMULATIONS OF VAGINAL LACTOBACILLUS [patent_app_type] => utility [patent_app_number] => 16/627118 [patent_app_country] => US [patent_app_date] => 2018-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13146 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -32 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16627118 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/627118
HIGH POTENCY STABLE FORMULATIONS OF VAGINAL LACTOBACILLUS Jul 4, 2018 Abandoned
Array ( [id] => 17489300 [patent_doc_number] => 11278581 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-03-22 [patent_title] => Use of vaginal [patent_app_type] => utility [patent_app_number] => 16/627248 [patent_app_country] => US [patent_app_date] => 2018-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11134 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16627248 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/627248
Use of vaginal Jul 4, 2018 Issued
Array ( [id] => 16296314 [patent_doc_number] => 20200282037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-10 [patent_title] => BACTERIAL VACCINE [patent_app_type] => utility [patent_app_number] => 16/622900 [patent_app_country] => US [patent_app_date] => 2018-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10033 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -108 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16622900 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/622900
BACTERIAL VACCINE Jun 14, 2018 Abandoned
Array ( [id] => 16009135 [patent_doc_number] => 20200179410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-11 [patent_title] => VITAMIN D COMPOUNDS AND METHODS OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 16/620376 [patent_app_country] => US [patent_app_date] => 2018-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6888 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16620376 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/620376
Vitamin D compounds and methods of using the same Jun 7, 2018 Issued
Array ( [id] => 16634336 [patent_doc_number] => 10912823 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-02-09 [patent_title] => Botulinum neurotoxin for treatment of disorders associated with melanocyte hyperactivity and/or excess melanin [patent_app_type] => utility [patent_app_number] => 15/992627 [patent_app_country] => US [patent_app_date] => 2018-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 7308 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15992627 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/992627
Botulinum neurotoxin for treatment of disorders associated with melanocyte hyperactivity and/or excess melanin May 29, 2018 Issued
Array ( [id] => 13593339 [patent_doc_number] => 20180348218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-06 [patent_title] => SEROLOGY ASSAY FOR RECENT MALARIA INFECTION [patent_app_type] => utility [patent_app_number] => 15/991355 [patent_app_country] => US [patent_app_date] => 2018-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5906 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -39 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15991355 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/991355
SEROLOGY ASSAY FOR RECENT MALARIA INFECTION May 28, 2018 Abandoned
Array ( [id] => 13440833 [patent_doc_number] => 20180271959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-27 [patent_title] => SUSTAINED RELEASE POLOXAMER CONTAINING PHARMACEUTICAL COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 15/989742 [patent_app_country] => US [patent_app_date] => 2018-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7076 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15989742 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/989742
SUSTAINED RELEASE POLOXAMER CONTAINING PHARMACEUTICAL COMPOSITIONS May 24, 2018 Abandoned
Array ( [id] => 13563849 [patent_doc_number] => 20180333472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-22 [patent_title] => TREATMENT OF PLANTAR FASCIITIS [patent_app_type] => utility [patent_app_number] => 15/978931 [patent_app_country] => US [patent_app_date] => 2018-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3715 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15978931 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/978931
TREATMENT OF PLANTAR FASCIITIS May 13, 2018 Abandoned
Array ( [id] => 13383613 [patent_doc_number] => 20180243348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-30 [patent_title] => HUMAN-DERIVED BACTERIA THAT INDUCE PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS [patent_app_type] => utility [patent_app_number] => 15/964285 [patent_app_country] => US [patent_app_date] => 2018-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33610 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15964285 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/964285
Human-derived bacteria that induce proliferation or accumulation of regulatory T cells Apr 26, 2018 Issued
Array ( [id] => 16762606 [patent_doc_number] => 20210108187 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-15 [patent_title] => BOTULINUM NEUROTOXINS PRODUCTION METHODS [patent_app_type] => utility [patent_app_number] => 16/608360 [patent_app_country] => US [patent_app_date] => 2018-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16854 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16608360 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/608360
BOTULINUM NEUROTOXINS PRODUCTION METHODS Apr 26, 2018 Abandoned
Array ( [id] => 13383735 [patent_doc_number] => 20180243409 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-30 [patent_title] => SYNTHETIC CONJUGATE OF CpG DNA AND T-HELP/CTL PEPTIDE [patent_app_type] => utility [patent_app_number] => 15/963173 [patent_app_country] => US [patent_app_date] => 2018-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11601 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15963173 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/963173
Synthetic conjugate of CpG DNA and T-help/CTL peptide Apr 25, 2018 Issued
Array ( [id] => 16491202 [patent_doc_number] => 10857220 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-12-08 [patent_title] => Staphylococcal coagulase antigens and methods of their use [patent_app_type] => utility [patent_app_number] => 15/962115 [patent_app_country] => US [patent_app_date] => 2018-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 19 [patent_no_of_words] => 44662 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15962115 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/962115
Staphylococcal coagulase antigens and methods of their use Apr 24, 2018 Issued
Array ( [id] => 16259986 [patent_doc_number] => 10751395 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-08-25 [patent_title] => Method of treating depression [patent_app_type] => utility [patent_app_number] => 15/957494 [patent_app_country] => US [patent_app_date] => 2018-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6016 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15957494 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/957494
Method of treating depression Apr 18, 2018 Issued
Array ( [id] => 15130083 [patent_doc_number] => 10478478 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-11-19 [patent_title] => Treatment of Raynaud's phenomenon using botulinum toxin type B [patent_app_type] => utility [patent_app_number] => 15/941089 [patent_app_country] => US [patent_app_date] => 2018-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3071 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15941089 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/941089
Treatment of Raynaud's phenomenon using botulinum toxin type B Mar 29, 2018 Issued
Array ( [id] => 15493251 [patent_doc_number] => 20200046814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-13 [patent_title] => BOTULINUM NEUROTOXINS FOR USE IN THERAPY [patent_app_type] => utility [patent_app_number] => 16/496011 [patent_app_country] => US [patent_app_date] => 2018-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12511 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -34 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16496011 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/496011
Botulinum neurotoxins for use in therapy Mar 21, 2018 Issued
Array ( [id] => 13462321 [patent_doc_number] => 20180282703 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-04 [patent_title] => NOVEL BACTERIOPHAGE AND ANTIBACTERIAL COMPOSITION COMPRISING THE SAME [patent_app_type] => utility [patent_app_number] => 15/925633 [patent_app_country] => US [patent_app_date] => 2018-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6087 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15925633 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/925633
Bacteriophage and antibacterial composition comprising the same Mar 18, 2018 Issued
Menu